High efficiency, small volume nucleic acid synthesis

US10519439B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10519439-B2
Application numberUS-201715463363-A
CountryUS
Kind codeB2
Filing dateMar 20, 2017
Priority dateSep 26, 2011
Publication dateDec 31, 2019
Grant dateDec 31, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The disclosure generally relates to compositions and methods for the production of nucleic acid molecules. In some aspects, the invention allows for the microscale generation of nucleic acid molecules, optionally followed by assembly of these nucleic acid molecules into larger molecules. In some aspects, the invention allows for efficient production of nucleic acid molecules (e.g., large nucleic acid molecules such as genomes).

First claim

Opening claim text (preview).

What is claimed is: 1. A method for producing a product nucleic acid molecule, the method comprising: (a) designing the product nucleic acid molecule; (b) synthesizing a plurality of nucleic acid molecules on separate beads in wells of a plate, wherein each well is configured to accommodate a single bead, wherein a subset of the nucleic acid molecules synthesized on the separate beads are components of the product nucleic acid molecule, wherein the volume of each well is between 0.1 picoliters and 10 nanoliters, wherein the wells comprise an electrode for the production of electrochemically generated acid, and wherein the individual nucleic acid molecules that are the components of the product nucleic acid molecule are capable of hybridizing with one or more of the other individual nucleic acid molecules that are the components of the product nucleic acid molecule; (c) selectively removing beads from the wells that comprise individual nucleic acid molecules that are the components of the product nucleic acid molecule, wherein beads comprising nucleic acid molecules that are not components of the product nucleic acid molecule are not removed from their respective wells; (d) collecting the beads selectively removed from wells in step (c) in a vessel; (e) releasing the nucleic acid molecules from the beads collected in the vessel in step (d) to form a pool of nucleic acid molecules in the vessel; and (f) assembling the product nucleic acid molecule from the pool of nucleic acid molecules formed in step (e). 2. The method of claim 1 , wherein the beads in the wells are porous beads. 3. The method of claim 1 , wherein the beads in the wells of the plate are monodispersed beads. 4. The method of claim 3 , wherein the monodispersed beads are between 10 μm and 40 μm in diameter. 5. The method of claim 1 , wherein synthesis of the nucleic acid molecules on the separate beads involves deblocking in step (b) by an acid generated by in a redox reaction mixture in the wells of the plate. 6. The method of claim 5 , wherein the redox reaction mixture in the wells of the plate contains hydroquinone. 7. The method of claim 6 , wherein the redox reaction mixture in the wells of the plate contains hydroquinone and anthraquinone. 8. The method of claim 6 , wherein the electrochemically generated acid is generated in the well by passing an electrical current through the wells. 9. The method of claim 5 , wherein the plate contains between 1,000 and 50,000 wells. 10. The method of claim 5 , wherein the plate contains a 10 mm 2 area which contains 10,000 wells. 11. The method of claim 1 , wherein the product nucleic acid molecule is between 0.5 kilobase and 100 kilobases in size. 12. The method of claim 1 , wherein the volume of each well is between 0.1 picoliters and 1 nanoliter. 13. The method of claim 1 , wherein the volume of each well is between 0.1 picoliters and 100 picoliters. 14. The method of claim 1 , wherein the average amount of nucleic acid synthesized on each bead is between 1 femtomole and 0.001 nanomole. 15. The method of claim 9 , wherein the number of beads selectively removed from wells of the plate is between 100 and 1,000.

Assignees

Inventors

Classifications

  • Means for dispensing and evacuation of reagents · CPC title

  • General methods for preparing the vector, for introducing it into the cell or for selecting the vector-containing host · CPC title

  • Sequential or parallel reactions, e.g. for the synthesis of polypeptides or polynucleotides; Apparatus and devices for combinatorial chemistry or for making molecular arrays (synthesis methods per se C40B50/00) · CPC title

  • General methods of preparing gene libraries, not provided for in other subgroups · CPC title

  • General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10519439B2 cover?
The disclosure generally relates to compositions and methods for the production of nucleic acid molecules. In some aspects, the invention allows for the microscale generation of nucleic acid molecules, optionally followed by assembly of these nucleic acid molecules into larger molecules. In some aspects, the invention allows for efficient production of nucleic acid molecules (e.g., large nuclei…
Who is the assignee on this patent?
Life Technologies Corp, Thermo Fisher Scient Geneart Gmbh
What technology area does this patent fall under?
Primary CPC classification B01J19/0046. Mapped technology areas include Operations & Transport.
When was this patent published?
Publication date Tue Dec 31 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).